Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederdrugs.com
Drugs.com - New Drug Approvals
Get the latest updates from Drugs.com - New Drug Approvals directly as they happen.
Follow now 78 followers
Latest posts
Last updated about 5 hours ago
FDA Approves Simtriyo (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
3 days ago
PRINCETON, N.J. and TOKYO, JAPAN – July 24, 2026 – Otsuka Pharmaceutical...
Celltrion Becomes First to Acquire U.S. Interchangeability Status for Truxima
27 days ago
July 1 , 2026 Celltrion announced on the 1st that it has...
MannKind Announces FDA Approval of Furoscix ReadyFlow, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
4 days ago
WESTLAKE VILLAGE, Calif., and BOSTON, July 24, 2026 (Globe Newswire) – MannKind...
FDA Approves Simtriyo (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
4 days ago
PRINCETON, N.J. and TOKYO, JAPAN – July 24, 2026 – Otsuka Pharmaceutical...
FDA Approves Lytenava (bevacizumab-vikg) for the Treatment of Wet Age-Related Macular Degeneration
4 days ago
ISELIN, N.J., July 24, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq...
FDA Approves Tylenol with Naproxen (acetaminophen and naproxen sodium) for Over-the-Counter Treatment of Pain
3 days ago
SUMMIT, N.J., July 24, 2026 — Tylenol®, the #1 doctor‑recommended pain relief...
FDA Approves Jideytro (zidesamtinib) for Previously Treated ROS1-Positive Non-Small Cell Lung Cancer
5 days ago
London, UK July 22, 2026 -- GSK plc (LSE/NYSE: GSK) today announced...
Glenmark Receives U.S. FDA Approval to Expand the Use of Ryaltris Nasal Spray for Children Aged 6 to Less Than 12 Years
6 days ago
Elmwood Park, New Jersey, July 21, 2026: Glenmark Specialty S.A. (Glenmark) today...
FDA Grants Traditional Approval to Retevmo (selpercatinib) for Locally Advanced or Metastatic RET Fusion-Positive Solid Tumors
13 days ago
On July 14, 2026, the Food and Drug Administration granted traditional approval...
Novartis Fabhalta (iptacopan) Receives FDA Traditional Approval as First and Only Complement Inhibitor to Significantly Slow Kidney Function Decline in Primary IgAN
10 days ago
Basel, July 17, 2026 – Novartis today announced that the US Food...
FDA Approves Lipfendra (enlicitide) Oral PCSK9 Inhibitor to Reduce LDL-C in Adults with Hypercholesterolemia
11 days ago
RAHWAY, N.J.--(BUSINESS WIRE) July 16, 2026 -- Merck (NYSE: MRK), known as...
Xeomin Approved For Expanded Indication in Pediatric Upper Limb Spasticity Patients with Cerebral Palsy Following FDA Label Update
about 1 month ago
RALEIGH, N.C. – June 26, 2026 – Merz Therapeutics announced today that...